Isomorphic Labs Ltd

11/19/2026 | Press release | Distributed by Public on 11/19/2026 06:12

Isomorphic Labs enters into a strategic research collaboration with MSD

Isomorphic Labs announces a strategic research collaboration with global pharmaceutical leader MSD. This collaboration brings together Isomorphic Labs' AI approach to drug discovery with MSD's rich proprietary data resources and deep discovery experience.

Isomorphic Labs has built a world-leading, modality-agnostic drug design engine (IsoDDE) comprised of foundational AI models. The computational drug-design system provides the predictive fidelity required to navigate novel biological systems with unprecedented accuracy.

The collaboration highlights the transformative power of bringing together advanced AI, unique data sets and established biopharmaceutical leadership to accelerate the advancement of therapeutic candidates for the benefit of patient populations with unmet needs.

Read more in the news release below.

‍

Isomorphic Labs Ltd published this content on November 19, 2026, and is solely responsible for the information contained herein. Distributed via Public Technologies (PUBT), unedited and unaltered, on November 19, 2026 at 12:12 UTC. If you believe the information included in the content is inaccurate or outdated and requires editing or removal, please contact us at [email protected]